Form 8-K - Current report:
SEC Accession No. 0001021408-02-011902
Filing Date
2002-09-18
Accepted
2002-09-18 09:15:42
Documents
2
Period of Report
2002-09-17
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 INCARA PHARMACEUTICALS CORPORATION d8k.txt 8-K 4004
3 PRESS RELEASE dex991.txt EX-99.1 3813
  Complete submission text file 0001021408-02-011902.txt   9654
Mailing Address PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-27410 | Film No.: 02766485
SIC: 2834 Pharmaceutical Preparations